New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

by Fred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainOver the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred H
Oncology January 30,2024
Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

by Fred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainOver the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred H
Oncology January 30,2024
Researchers discuss reassessing COVID-19 precautions in 2023

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget
Oncology January 30,2024
Researchers discuss reassessing COVID-19 precautions in 2023

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget
Oncology January 30,2024
Heart disease prevention is particularly important in cancer patients

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate
Oncology January 30,2024
Heart disease prevention is particularly important in cancer patients

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate
Oncology January 30,2024
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance
Oncology January 30,2024
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance
Oncology January 30,2024
Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C
Oncology January 30,2024
Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C
Oncology January 30,2024
A potentially novel approach to improving the efficacy of natural killer cell therapies

A potentially novel approach to improving the efficacy of natural killer cell therapies

by Ludwig Cancer ResearchGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.030Natural killer (NK) cells have lately become a hot focus of efforts to develop new immun
Oncology January 30,2024
A potentially novel approach to improving the efficacy of natural killer cell therapies

A potentially novel approach to improving the efficacy of natural killer cell therapies

by Ludwig Cancer ResearchGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.030Natural killer (NK) cells have lately become a hot focus of efforts to develop new immun
Oncology January 30,2024
New genetic culprit suspected in the onset of pancreatic cancer

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat
Oncology January 30,2024
New genetic culprit suspected in the onset of pancreatic cancer

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat
Oncology January 30,2024
Dangers of late cervical cancer diagnosis in women of color

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr
Oncology January 30,2024
Dangers of late cervical cancer diagnosis in women of color

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr
Oncology January 30,2024
A DNA protein may be responsible for causing cancerous 'stress balls' in the body

A DNA protein may be responsible for causing cancerous 'stress balls' in the body

by Brooke Kleiboer,University of SaskatchewanCredit: Pixabay/CC0 Public DomainIn 2022, an estimated 7,000 Canadians were diagnosed with leukemia, a term used to define cancer of the blood cells.
Oncology January 30,2024
A DNA protein may be responsible for causing cancerous 'stress balls' in the body

A DNA protein may be responsible for causing cancerous 'stress balls' in the body

by Brooke Kleiboer,University of SaskatchewanCredit: Pixabay/CC0 Public DomainIn 2022, an estimated 7,000 Canadians were diagnosed with leukemia, a term used to define cancer of the blood cells.
Oncology January 30,2024
Study shows a new approach to target a deadly form of prostate cancer

Study shows a new approach to target a deadly form of prostate cancer

by University of MichiganGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.167440A study from the University of Michigan Rogel Cancer Center uncovers a new mechan
Oncology January 30,2024
Study shows a new approach to target a deadly form of prostate cancer

Study shows a new approach to target a deadly form of prostate cancer

by University of MichiganGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.167440A study from the University of Michigan Rogel Cancer Center uncovers a new mechan
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com